Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.200
-0.080 (-6.25%)
At close: May 13, 2025, 4:00 PM
1.230
+0.030 (2.50%)
After-hours: May 13, 2025, 7:56 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Therapeutic Products for Oncology
76.99M
Log In
Log In
Log In
Log In
Upgrade
Therapeutic Products for Oncology Growth
32386.92%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
76.99M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
32386.92%
Log In
Log In
Log In
Log In
Upgrade